XTX Topco Ltd bought a new position in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) in the first quarter, according to its most recent filing with the SEC. The firm bought 126,572 shares of the company's stock, valued at approximately $4,331,000.
A number of other institutional investors also recently bought and sold shares of KDP. Price T Rowe Associates Inc. MD boosted its stake in Keurig Dr Pepper by 36.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company's stock worth $1,755,564,000 after purchasing an additional 14,473,054 shares in the last quarter. Norges Bank acquired a new stake in Keurig Dr Pepper in the 4th quarter worth approximately $197,819,000. Wellington Management Group LLP boosted its stake in Keurig Dr Pepper by 10.3% in the 4th quarter. Wellington Management Group LLP now owns 60,602,781 shares of the company's stock worth $1,946,561,000 after purchasing an additional 5,646,179 shares in the last quarter. Invesco Ltd. boosted its stake in Keurig Dr Pepper by 19.6% in the 4th quarter. Invesco Ltd. now owns 21,605,610 shares of the company's stock worth $693,972,000 after purchasing an additional 3,539,463 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in Keurig Dr Pepper by 20.6% in the 4th quarter. Northern Trust Corp now owns 13,598,633 shares of the company's stock worth $436,788,000 after purchasing an additional 2,320,614 shares in the last quarter. 93.99% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of analysts recently commented on the stock. Argus assumed coverage on shares of Keurig Dr Pepper in a research note on Wednesday, April 16th. They issued a "buy" rating and a $40.00 target price for the company. JPMorgan Chase & Co. decreased their price objective on shares of Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating for the company in a research note on Thursday, July 17th. Barclays restated an "overweight" rating and set a $39.00 price objective (up from $37.00) on shares of Keurig Dr Pepper in a research note on Monday, July 28th. Royal Bank Of Canada restated an "outperform" rating and set a $42.00 price objective on shares of Keurig Dr Pepper in a research note on Tuesday, April 22nd. Finally, UBS Group decreased their price objective on shares of Keurig Dr Pepper from $42.00 to $40.00 and set a "buy" rating for the company in a research note on Thursday, July 17th. Two analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $39.77.
Check Out Our Latest Stock Report on KDP
Keurig Dr Pepper Stock Performance
Shares of NASDAQ:KDP traded up $0.67 during trading on Friday, hitting $33.32. 11,675,843 shares of the stock traded hands, compared to its average volume of 10,397,284. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56. The company has a market cap of $45.26 billion, a price-to-earnings ratio of 29.75, a P/E/G ratio of 2.38 and a beta of 0.45. The company has a fifty day moving average price of $33.26 and a two-hundred day moving average price of $33.34. Keurig Dr Pepper, Inc has a 52-week low of $30.12 and a 52-week high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its earnings results on Thursday, July 24th. The company reported $0.49 earnings per share for the quarter, meeting the consensus estimate of $0.49. The firm had revenue of $4.16 billion during the quarter, compared to analyst estimates of $4.14 billion. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. The business's quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.45 EPS. As a group, equities analysts predict that Keurig Dr Pepper, Inc will post 1.92 EPS for the current year.
Keurig Dr Pepper Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were issued a $0.23 dividend. This represents a $0.92 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend was Friday, June 27th. Keurig Dr Pepper's payout ratio is presently 82.14%.
Insider Activity at Keurig Dr Pepper
In related news, insider Mary Beth Denooyer sold 12,000 shares of the business's stock in a transaction on Thursday, July 17th. The shares were sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the sale, the insider owned 82,511 shares of the company's stock, valued at approximately $2,777,320.26. The trade was a 12.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director De Ven Michael G. Van purchased 15,000 shares of the business's stock in a transaction that occurred on Wednesday, June 4th. The stock was bought at an average cost of $33.20 per share, with a total value of $498,000.00. Following the acquisition, the director owned 15,000 shares in the company, valued at $498,000. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders sold a total of 490,500 shares of company stock worth $16,298,360 in the last quarter. 0.40% of the stock is owned by insiders.
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Read More

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report